4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Axogen, Inc. (AXGN) operates in the Medical Devices industry and is headquartered in Alachua, United States with about 622 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, AXGN reported $225M in revenue and ($16M) in net income.
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide.
Interactive charts & full statements → Open the AXGN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $225M | $187M | $159M | $139M |
| Gross Profit | $167M | $142M | $122M | $109M |
| Operating Income (EBIT) | ($8M) | ($3M) | ($22M) | ($30M) |
| Net Income | ($16M) | ($10M) | ($22M) | ($29M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $62M | $60M | $60M | $57M | $49M |
| Gross Profit | $46M | $44M | $46M | $42M | $35M |
| Operating Income (EBIT) | ($3M) | ($10M) | $2M | $2M | ($2M) |
| Net Income | ($20M) | ($13M) | $1M | $1M | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $222M | $204M | $197M | $195M | — |
| Total Liabilities | $93M | $100M | $101M | $94M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AXGN viewer.
About TickerBase · Data methodology & sources